[go: up one dir, main page]

PT1333812E - Microgrânulos à base de princípio activo e processo de fabrico do mesmo - Google Patents

Microgrânulos à base de princípio activo e processo de fabrico do mesmo Download PDF

Info

Publication number
PT1333812E
PT1333812E PT01996363T PT01996363T PT1333812E PT 1333812 E PT1333812 E PT 1333812E PT 01996363 T PT01996363 T PT 01996363T PT 01996363 T PT01996363 T PT 01996363T PT 1333812 E PT1333812 E PT 1333812E
Authority
PT
Portugal
Prior art keywords
active principle
making same
core
microgranules
coated
Prior art date
Application number
PT01996363T
Other languages
English (en)
Inventor
Edouard Gendrot
Etienne Bruna
Gerard Cousin
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of PT1333812E publication Critical patent/PT1333812E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micromachines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT01996363T 2000-11-16 2001-11-15 Microgrânulos à base de princípio activo e processo de fabrico do mesmo PT1333812E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014803A FR2816507B1 (fr) 2000-11-16 2000-11-16 Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules

Publications (1)

Publication Number Publication Date
PT1333812E true PT1333812E (pt) 2008-03-17

Family

ID=8856551

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01996363T PT1333812E (pt) 2000-11-16 2001-11-15 Microgrânulos à base de princípio activo e processo de fabrico do mesmo

Country Status (15)

Country Link
US (1) US7829122B2 (pt)
EP (1) EP1333812B1 (pt)
JP (1) JP4234427B2 (pt)
CN (1) CN1222277C (pt)
AT (1) ATE387187T1 (pt)
AU (2) AU2002223074B2 (pt)
CA (1) CA2427899C (pt)
DE (1) DE60133028T2 (pt)
DK (1) DK1333812T3 (pt)
ES (1) ES2300384T3 (pt)
FR (1) FR2816507B1 (pt)
HK (1) HK1063017A1 (pt)
MX (1) MXPA03004300A (pt)
PT (1) PT1333812E (pt)
WO (1) WO2002039981A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
LT2522365T (lt) 2004-11-24 2017-02-10 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
CN101912360A (zh) * 2010-07-13 2010-12-15 山东达因海洋生物制药股份有限公司 布洛芬混悬液及其制备方法
ES2673286T3 (es) 2011-02-11 2018-06-21 Zx Pharma, Llc Formulaciones multiparticuladas de L-mentol y métodos relacionados
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
SMT201900021T1 (it) 2013-04-23 2019-02-28 Zx Pharma Llc Composizione gastroresistente a base di multiparticolato con sottorivestimento proteinaceo
KR102019645B1 (ko) * 2019-02-21 2019-09-09 한국화학연구원 염기성오염물질 제거용 비드 및 이의 제조방법
CN111184694A (zh) * 2020-01-19 2020-05-22 广东青云山药业有限公司 一种口腔速溶颗粒的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
IT1115596B (it) 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
ES2199981T3 (es) 1994-02-16 2004-03-01 Abbott Laboratories Modo de preparacion de formulaciones farmaceuticas de particulas finas.
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
ATE387187T1 (de) 2008-03-15
JP4234427B2 (ja) 2009-03-04
DE60133028T2 (de) 2009-03-12
US7829122B2 (en) 2010-11-09
ES2300384T3 (es) 2008-06-16
US20040101568A1 (en) 2004-05-27
EP1333812B1 (fr) 2008-02-27
WO2002039981A1 (fr) 2002-05-23
EP1333812A1 (fr) 2003-08-13
AU2307402A (en) 2002-05-27
MXPA03004300A (es) 2004-09-10
CA2427899C (fr) 2011-05-10
CA2427899A1 (fr) 2002-05-23
AU2002223074B2 (en) 2005-03-10
FR2816507A1 (fr) 2002-05-17
CN1222277C (zh) 2005-10-12
DK1333812T3 (da) 2008-03-31
JP2004517064A (ja) 2004-06-10
HK1063017A1 (en) 2004-12-10
CN1481235A (zh) 2004-03-10
FR2816507B1 (fr) 2003-02-28
DE60133028D1 (de) 2008-04-10

Similar Documents

Publication Publication Date Title
AU2307402A (en) Microgranules based on active principle and method for making same
ES2157731A1 (es) Preparacion farmaceutica oral de un compuesto de anticidad antifungica y procedimiento para su preparacion.
WO2004030652A3 (en) Dosage form having an inner core and at least two coating layers
CA2328998A1 (en) Method of fabricating a banded prolonged release active agent dosage form
PL342044A1 (en) Omeprazole containing microgranules protected against gastric secretions, method of obtaining them and pharmacological preparations
DE59507193D1 (de) VERFAHREN ZU hERSTELLUNG EINER MANTELTABLETTE MIT SPITZEM KERN
CA2234036A1 (en) Multi-core, multi-cover golf ball
GR3030451T3 (en) Synergistic termiticidal composition of pyrethroid and n-phenyl-pyrazole
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
BG103356A (en) Fungicide and polymer coated core-containing pellets
BG105484A (en) Implant with cavitiies containing therapeutic agents
DE69835139D1 (de) Fäulnisverhindernde emulsionsbeschichtungszusammensetzung, verfahren zur herstellung und mit dieser fäulnisverhindernden zusammensetzung beschichteter gegenstand
IL130339A0 (en) Improved multiparticulate tablet with quick disintegration
MXPA05008161A (es) Composicion que comprende una mezcla de principios activos, y metodo de preparacion.
CA2278418A1 (en) Epoxy coated tampon applicator having a pierce-through fingergrip
AU4683397A (en) Composite melanin pigment in the form of particles comprising a wax-based spherical core, preparation processes and cosmetic uses
GB2337938A (en) Golf ball and method of making same
NO20011903D0 (no) Partikler
GB2343117A (en) Benzimidazole pharmaceutical composition and process of preparation
AU2002223074A1 (en) Microgranules based on active principle and method for making same
WO2002072072A3 (fr) Granules et granules enrobes au gout masque
WO2002060135A3 (en) Approach for transferring functions between participants in a communications arrangement
ES2183970T3 (es) Procedimiento de fabricacion de granulos y granulos asi obtenidos.
AU5488198A (en) Method for coating cheese and resulting coated cheese
CA2259407A1 (en) Drug delivery devices and process of manufacture